Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINJECTIONGeneric

CEFOXITIN

CEFOXITIN SODIUM

Standard Dose
EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview CEFOXITIN is listed in Drugs@FDA under application 065012 (ANDA).
  • Marketing status: Discontinued Active ingredient CEFOXITIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2007-11-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFOXITIN is listed in Drugs@FDA under application 065012 (ANDA). Marketing status: Discontinued Active ingredient CEFOXITIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2007-11-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.